Detalles de la búsqueda
1.
Comparative performance of scFv-based anti-BCMA CAR formats for improved T cell therapy in multiple myeloma.
Cancer Immunol Immunother
; 73(6): 100, 2024 Apr 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-38630291
2.
Age Is a Prognostic Factor for the Overall Survival of Patients with Multiple Myeloma Undergoing Upfront Autologous Hematopoietic Stem Cell Transplantation.
Biol Blood Marrow Transplant
; 26(6): 1077-1083, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31786242
3.
MAP3K7 is recurrently deleted in pediatric T-lymphoblastic leukemia and affects cell proliferation independently of NF-κB.
BMC Cancer
; 18(1): 663, 2018 Jun 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-29914415
4.
Survival and immunotoxicities in association with sex-specific body composition patterns of cancer patients undergoing immune-checkpoint inhibitor therapy - A systematic review and meta-analysis.
Eur J Cancer
; 184: 151-171, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36931074
5.
The CAR-HEMATOTOX score as a prognostic model of toxicity and response in patients receiving BCMA-directed CAR-T for relapsed/refractory multiple myeloma.
J Hematol Oncol
; 16(1): 88, 2023 07 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-37525244
6.
Influence of Adipose Tissue Distribution, Sarcopenia, and Nutritional Status on Clinical Outcomes After CD19 CAR T-cell Therapy.
Cancer Immunol Res
; 11(6): 707-719, 2023 06 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-37040425
7.
Identifying Early Infections in the Setting of CRS With Routine and Exploratory Serum Proteomics and the HT10 Score Following CD19 CAR-T for Relapsed/Refractory B-NHL.
Hemasphere
; 7(4): e858, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-37038465
8.
Risk Stratification Based on a Pattern of Immunometabolic Host Factors Is Superior to Body Mass Index-Based Prediction of COVID-19-Associated Respiratory Failure.
Nutrients
; 14(20)2022 Oct 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-36296963
9.
Profound response to venetoclax monotherapy in a patient with BCL-2 positive relapsed multiple myeloma and extramedullary CNS manifestations.
Leuk Lymphoma
; 63(11): 2706-2710, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35793435
Resultados
1 -
9
de 9
1
Próxima >
>>